Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Murray, Nigel P.
Text and Data Mining valid from 2018-09-04
21 March 2018
28 August 2018
4 September 2018